US Patent Issued to Board of Regents, The University of Texas System on Nov. 18 for "Systems and methods for spectral imaging characterization of macrophages for use in personalization of targeted therapies to prevent fibrosis development in patients with chronic liver disease" (Texas Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,474,339, issued on Nov. 18, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Systems and methods for spectral imaging characterization of macrophages for use in personalization of targeted therapies to prevent fibrosis development in patients with chronic liver disease" was invented by Heather Stevenson (Galveston, Texas) and Omar Saldarriaga (League City, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes a method of macrophage phenotype profiling for the assessment, determination, and stratification of risk of development of fibrosis and/or cirrhosis within the liver, and treatment the...